The discovery of the first mRNA-stabilizing substance could pave the way for groundbreaking advancements in the development ...
The Therapeutic Goods Administration (TGA) is aware of misinformation in recent media and online reports that claim the COVID ...
In an era where viral outbreaks can escalate into global pandemics with alarming speed, the ability to quickly develop new ...
New non-human primate data show highly selective in vivo delivery of mRNA to T cells with a cell-targeted lipid nanoparticle ...
Researchers are developing what they hope will be the first successful vaccine against the highly contagious and difficult-to ...
Long known as a messenger within cells, RNA is increasingly seen as life’s molecular communication system—even between ...
Generation Bio (GBIO) presented data on its cell-targeted lipid nanoparticle – ctLNP – and immune-quiet DNA – iqDNA – ...
A new vaccine provides hope for treating and even preventing the highly contagious and difficult-to-treat Clostridioides difficile infection, more commonly known as C. difficile or C. diff. In animal ...
The global mRNA synthesis and manufacturing market is projected to grow from USD 624.4 million in 2024 to USD 738.3 million ...
Researchers at the University of Toronto have shown that an important class of DNA-binding factors can also bind to RNA, regulating gene expression through various mechanisms. The study significantly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback